Results 131 to 140 of about 1,598,085 (291)
Status and outlook of pulmonary tuberculosis coinfection. [PDF]
Wu Y, Wang C, Li Y.
europepmc +1 more source
The Polythene Pack Operation for Pulmonary Tuberculosis [PDF]
Huw M. L. Davies+2 more
openalex +1 more source
This cohort study of 1793 atopic dermatitis patients (aged ≥ 12) found higher infection rates with Janus kinase inhibitor treatment compared to biologic treatment, particularly for herpes infections, with a history of viral or fungal skin infection as a risk factor associated with infection.
Lian F. van der Gang+22 more
wiley +1 more source
Characteristics of subclinical pulmonary tuberculosis compared to active pulmonary tuberculosis: A retrospective cohort study. [PDF]
Zhang A+4 more
europepmc +1 more source
ABSTRACT Rifampin is an enigma among antimicrobials. Blood and tissue compartment concentrations are a “moving target” along the treatment course due to the complex pharmacodynamic interactions within the body. Rifampin concomitant therapies are for the prevention and treatment of Rhodococcus equi infection in foals, for nearly 40 years.
Keith Edward Baptiste+4 more
wiley +1 more source
Analysis of the epidemiological characteristics of pulmonary tuberculosis in Shijiazhuang, China 2010-2023. [PDF]
Wang X, Guo J, Shi X, Cui L.
europepmc +1 more source
THE CUTANEOUS AND CONJUNCTIVAL TUBERCULIN TESTS IN THE DIAGNOSIS OF PULMONARY TUBERCULOSIS [PDF]
Louis Hamman
openalex +1 more source
The Dental Status of Patients Taking Common Biologic Agents: A Single‐Center Cross‐Sectional Study
ABSTRACT Objectives Despite expanding use and medical applications, little is known about the impact of biologic agents (BAs) on dental treatment. The aim of this study was to investigate the dental status of patients on common classes of BAs to understand treatment needs and use in this population.
Shivani Shah+4 more
wiley +1 more source